nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenelzine—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.0426	0.0917	CcSEcCtD
Phenelzine—AOC3—peripheral nervous system—amyotrophic lateral sclerosis	0.0381	0.116	CbGeAlD
Phenelzine—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.0245	0.0527	CcSEcCtD
Phenelzine—Mania—Riluzole—amyotrophic lateral sclerosis	0.0231	0.0498	CcSEcCtD
Phenelzine—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.0223	0.0481	CcSEcCtD
Phenelzine—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.02	0.0431	CcSEcCtD
Phenelzine—Delirium—Riluzole—amyotrophic lateral sclerosis	0.0196	0.0421	CcSEcCtD
Phenelzine—ABAT—hindbrain—amyotrophic lateral sclerosis	0.0188	0.0575	CbGeAlD
Phenelzine—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.0168	0.0362	CcSEcCtD
Phenelzine—Coma—Riluzole—amyotrophic lateral sclerosis	0.0154	0.0331	CcSEcCtD
Phenelzine—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.0148	0.0318	CcSEcCtD
Phenelzine—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.0145	0.0311	CcSEcCtD
Phenelzine—ABAT—GABA synthesis, release, reuptake and degradation—SLC6A1—amyotrophic lateral sclerosis	0.0141	0.0676	CbGpPWpGaD
Phenelzine—MAOB—nerve—amyotrophic lateral sclerosis	0.0122	0.0373	CbGeAlD
Phenelzine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.0119	0.0257	CcSEcCtD
Phenelzine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.0116	0.025	CcSEcCtD
Phenelzine—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.0115	0.0247	CcSEcCtD
Phenelzine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.0112	0.024	CcSEcCtD
Phenelzine—ABAT—brainstem—amyotrophic lateral sclerosis	0.0108	0.0329	CbGeAlD
Phenelzine—MAOA—nerve—amyotrophic lateral sclerosis	0.0104	0.0319	CbGeAlD
Phenelzine—GPT2—medulla oblongata—amyotrophic lateral sclerosis	0.0102	0.0313	CbGeAlD
Phenelzine—GPT—nervous system—amyotrophic lateral sclerosis	0.0101	0.0308	CbGeAlD
Phenelzine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00972	0.0209	CcSEcCtD
Phenelzine—GPT—central nervous system—amyotrophic lateral sclerosis	0.00969	0.0296	CbGeAlD
Phenelzine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00961	0.0207	CcSEcCtD
Phenelzine—GPT—cerebellum—amyotrophic lateral sclerosis	0.00947	0.0289	CbGeAlD
Phenelzine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00918	0.0198	CcSEcCtD
Phenelzine—MAOB—hindbrain—amyotrophic lateral sclerosis	0.00916	0.028	CbGeAlD
Phenelzine—GPT2—spinal cord—amyotrophic lateral sclerosis	0.00913	0.0279	CbGeAlD
Phenelzine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00902	0.0194	CcSEcCtD
Phenelzine—AOC3—medulla oblongata—amyotrophic lateral sclerosis	0.0089	0.0272	CbGeAlD
Phenelzine—ABAT—Neurotransmitter Release Cycle—CHAT—amyotrophic lateral sclerosis	0.00837	0.0402	CbGpPWpGaD
Phenelzine—GPT2—Amino acid and derivative metabolism—DAO—amyotrophic lateral sclerosis	0.00837	0.0402	CbGpPWpGaD
Phenelzine—MAOA—hindbrain—amyotrophic lateral sclerosis	0.00781	0.0239	CbGeAlD
Phenelzine—GPT2—nervous system—amyotrophic lateral sclerosis	0.0077	0.0235	CbGeAlD
Phenelzine—GPT—brain—amyotrophic lateral sclerosis	0.00769	0.0235	CbGeAlD
Phenelzine—ABAT—medulla oblongata—amyotrophic lateral sclerosis	0.00752	0.023	CbGeAlD
Phenelzine—ABAT—Neurotransmitter Release Cycle—SLC6A1—amyotrophic lateral sclerosis	0.00746	0.0358	CbGpPWpGaD
Phenelzine—GPT2—central nervous system—amyotrophic lateral sclerosis	0.00741	0.0226	CbGeAlD
Phenelzine—GPT2—cerebellum—amyotrophic lateral sclerosis	0.00724	0.0221	CbGeAlD
Phenelzine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00714	0.0154	CcSEcCtD
Phenelzine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00689	0.0148	CcSEcCtD
Phenelzine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00683	0.0147	CcSEcCtD
Phenelzine—GPT—Amino acid and derivative metabolism—DAO—amyotrophic lateral sclerosis	0.00682	0.0328	CbGpPWpGaD
Phenelzine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00676	0.0146	CcSEcCtD
Phenelzine—ABAT—spinal cord—amyotrophic lateral sclerosis	0.0067	0.0205	CbGeAlD
Phenelzine—AOC3—nervous system—amyotrophic lateral sclerosis	0.00669	0.0204	CbGeAlD
Phenelzine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00663	0.0143	CcSEcCtD
Phenelzine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00658	0.0142	CcSEcCtD
Phenelzine—AOC3—central nervous system—amyotrophic lateral sclerosis	0.00644	0.0197	CbGeAlD
Phenelzine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.00637	0.0137	CcSEcCtD
Phenelzine—AOC3—cerebellum—amyotrophic lateral sclerosis	0.00629	0.0192	CbGeAlD
Phenelzine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00624	0.0134	CcSEcCtD
Phenelzine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00619	0.0133	CcSEcCtD
Phenelzine—MAOA—Biogenic Amine Synthesis—CHAT—amyotrophic lateral sclerosis	0.00613	0.0294	CbGpPWpGaD
Phenelzine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00612	0.0132	CcSEcCtD
Phenelzine—MAOB—Dopamine metabolism—SOD1—amyotrophic lateral sclerosis	0.00603	0.029	CbGpPWpGaD
Phenelzine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.006	0.0129	CcSEcCtD
Phenelzine—Shock—Riluzole—amyotrophic lateral sclerosis	0.00591	0.0127	CcSEcCtD
Phenelzine—GPT2—brain—amyotrophic lateral sclerosis	0.00588	0.018	CbGeAlD
Phenelzine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00586	0.0126	CcSEcCtD
Phenelzine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.0058	0.0125	CcSEcCtD
Phenelzine—MAOB—embryo—amyotrophic lateral sclerosis	0.00573	0.0175	CbGeAlD
Phenelzine—ABAT—nervous system—amyotrophic lateral sclerosis	0.00565	0.0173	CbGeAlD
Phenelzine—MAOA—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.00561	0.027	CbGpPWpGaD
Phenelzine—ABAT—central nervous system—amyotrophic lateral sclerosis	0.00544	0.0166	CbGeAlD
Phenelzine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00543	0.0117	CcSEcCtD
Phenelzine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00539	0.0116	CcSEcCtD
Phenelzine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00534	0.0115	CcSEcCtD
Phenelzine—ABAT—cerebellum—amyotrophic lateral sclerosis	0.00532	0.0162	CbGeAlD
Phenelzine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00528	0.0114	CcSEcCtD
Phenelzine—MAOB—brainstem—amyotrophic lateral sclerosis	0.00525	0.016	CbGeAlD
Phenelzine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00518	0.0112	CcSEcCtD
Phenelzine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00518	0.0111	CcSEcCtD
Phenelzine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00513	0.0111	CcSEcCtD
Phenelzine—AOC3—brain—amyotrophic lateral sclerosis	0.00511	0.0156	CbGeAlD
Phenelzine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00495	0.0107	CcSEcCtD
Phenelzine—MAOA—embryo—amyotrophic lateral sclerosis	0.00489	0.0149	CbGeAlD
Phenelzine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00475	0.0102	CcSEcCtD
Phenelzine—MAOA—brainstem—amyotrophic lateral sclerosis	0.00448	0.0137	CbGeAlD
Phenelzine—ABAT—brain—amyotrophic lateral sclerosis	0.00432	0.0132	CbGeAlD
Phenelzine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00431	0.00928	CcSEcCtD
Phenelzine—MAOA—Oxidative Stress—GSR—amyotrophic lateral sclerosis	0.00429	0.0206	CbGpPWpGaD
Phenelzine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00425	0.00915	CcSEcCtD
Phenelzine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00397	0.00855	CcSEcCtD
Phenelzine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00382	0.00822	CcSEcCtD
Phenelzine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00379	0.00815	CcSEcCtD
Phenelzine—MAOA—Dopamine metabolism—SOD1—amyotrophic lateral sclerosis	0.00378	0.0182	CbGpPWpGaD
Phenelzine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00378	0.00814	CcSEcCtD
Phenelzine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00376	0.0081	CcSEcCtD
Phenelzine—MAOB—medulla oblongata—amyotrophic lateral sclerosis	0.00366	0.0112	CbGeAlD
Phenelzine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00357	0.00768	CcSEcCtD
Phenelzine—MAOB—spinal cord—amyotrophic lateral sclerosis	0.00326	0.00997	CbGeAlD
Phenelzine—CYP2C8—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—amyotrophic lateral sclerosis	0.00321	0.0154	CbGpPWpGaD
Phenelzine—ABAT—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00317	0.0152	CbGpPWpGaD
Phenelzine—MAOA—medulla oblongata—amyotrophic lateral sclerosis	0.00312	0.00954	CbGeAlD
Phenelzine—ABAT—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00293	0.014	CbGpPWpGaD
Phenelzine—ABAT—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00283	0.0136	CbGpPWpGaD
Phenelzine—MAOA—spinal cord—amyotrophic lateral sclerosis	0.00278	0.0085	CbGeAlD
Phenelzine—MAOB—nervous system—amyotrophic lateral sclerosis	0.00275	0.0084	CbGeAlD
Phenelzine—MAOA—Neurotransmitter Release Cycle—CHAT—amyotrophic lateral sclerosis	0.00269	0.0129	CbGpPWpGaD
Phenelzine—CYP2C19—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.00266	0.0128	CbGpPWpGaD
Phenelzine—MAOB—central nervous system—amyotrophic lateral sclerosis	0.00265	0.00809	CbGeAlD
Phenelzine—MAOB—cerebellum—amyotrophic lateral sclerosis	0.00259	0.0079	CbGeAlD
Phenelzine—ABAT—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00258	0.0124	CbGpPWpGaD
Phenelzine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00247	0.0119	CbGpPWpGaD
Phenelzine—ABAT—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00243	0.0117	CbGpPWpGaD
Phenelzine—ABAT—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0024	0.0115	CbGpPWpGaD
Phenelzine—ABAT—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0024	0.0115	CbGpPWpGaD
Phenelzine—MAOA—Neurotransmitter Release Cycle—SLC6A1—amyotrophic lateral sclerosis	0.0024	0.0115	CbGpPWpGaD
Phenelzine—MAOA—nervous system—amyotrophic lateral sclerosis	0.00235	0.00717	CbGeAlD
Phenelzine—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.00234	0.00716	CbGeAlD
Phenelzine—MAOA—central nervous system—amyotrophic lateral sclerosis	0.00226	0.0069	CbGeAlD
Phenelzine—ABAT—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00224	0.0108	CbGpPWpGaD
Phenelzine—MAOA—cerebellum—amyotrophic lateral sclerosis	0.00221	0.00674	CbGeAlD
Phenelzine—CYP3A43—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.0022	0.0106	CbGpPWpGaD
Phenelzine—ABAT—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.00217	0.0104	CbGpPWpGaD
Phenelzine—ABAT—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00214	0.0103	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00213	0.0102	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00213	0.0102	CbGpPWpGaD
Phenelzine—MAOB—brain—amyotrophic lateral sclerosis	0.0021	0.00642	CbGeAlD
Phenelzine—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.00209	0.00638	CbGeAlD
Phenelzine—CYP2E1—Vitamin A and Carotenoid Metabolism—RARA—amyotrophic lateral sclerosis	0.00205	0.00984	CbGpPWpGaD
Phenelzine—ABAT—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.00198	0.00951	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00194	0.00933	CbGpPWpGaD
Phenelzine—MAOA—Oxidative Stress—SOD1—amyotrophic lateral sclerosis	0.00194	0.00931	CbGpPWpGaD
Phenelzine—ABAT—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00184	0.00884	CbGpPWpGaD
Phenelzine—ABAT—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00184	0.00884	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00181	0.00868	CbGpPWpGaD
Phenelzine—MAOA—brain—amyotrophic lateral sclerosis	0.00179	0.00548	CbGeAlD
Phenelzine—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.00176	0.00538	CbGeAlD
Phenelzine—GPT—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00173	0.00832	CbGpPWpGaD
Phenelzine—GPT—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00173	0.00832	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—FIG4—amyotrophic lateral sclerosis	0.0017	0.00816	CbGpPWpGaD
Phenelzine—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.0017	0.00518	CbGeAlD
Phenelzine—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.00166	0.00506	CbGeAlD
Phenelzine—ABAT—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00164	0.00788	CbGpPWpGaD
Phenelzine—CYP2C8—brain—amyotrophic lateral sclerosis	0.0016	0.00488	CbGeAlD
Phenelzine—GPT—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00158	0.00761	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—DAO—amyotrophic lateral sclerosis	0.00154	0.00738	CbGpPWpGaD
Phenelzine—GPT—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00147	0.00707	CbGpPWpGaD
Phenelzine—MAOA—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.00147	0.00706	CbGpPWpGaD
Phenelzine—MAOA—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00146	0.00702	CbGpPWpGaD
Phenelzine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00142	0.00433	CbGeAlD
Phenelzine—GPT—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00139	0.00665	CbGpPWpGaD
Phenelzine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00136	0.00417	CbGeAlD
Phenelzine—CYP2E1—brain—amyotrophic lateral sclerosis	0.00135	0.00411	CbGeAlD
Phenelzine—GPT—Metabolism—DAO—amyotrophic lateral sclerosis	0.00125	0.00601	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00116	0.00559	CbGpPWpGaD
Phenelzine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00115	0.00551	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—GSR—amyotrophic lateral sclerosis	0.00107	0.00516	CbGpPWpGaD
Phenelzine—MAOA—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.00102	0.00489	CbGpPWpGaD
Phenelzine—CYP3A43—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000984	0.00473	CbGpPWpGaD
Phenelzine—CYP3A43—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000971	0.00466	CbGpPWpGaD
Phenelzine—GPT—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000949	0.00456	CbGpPWpGaD
Phenelzine—MAOA—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000942	0.00452	CbGpPWpGaD
Phenelzine—MAOA—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000942	0.00452	CbGpPWpGaD
Phenelzine—MAOA—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000942	0.00452	CbGpPWpGaD
Phenelzine—MAOA—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.00094	0.00451	CbGpPWpGaD
Phenelzine—MAOA—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000908	0.00436	CbGpPWpGaD
Phenelzine—CYP3A7—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000886	0.00425	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000883	0.00424	CbGpPWpGaD
Phenelzine—GPT—Metabolism—GSR—amyotrophic lateral sclerosis	0.000876	0.00421	CbGpPWpGaD
Phenelzine—MAOA—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.00083	0.00399	CbGpPWpGaD
Phenelzine—MAOA—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00078	0.00375	CbGpPWpGaD
Phenelzine—MAOA—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000772	0.00371	CbGpPWpGaD
Phenelzine—MAOA—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000772	0.00371	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000754	0.00362	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000754	0.00362	CbGpPWpGaD
Phenelzine—MAOB—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000746	0.00358	CbGpPWpGaD
Phenelzine—MAOA—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00072	0.00346	CbGpPWpGaD
Phenelzine—GPT—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000719	0.00345	CbGpPWpGaD
Phenelzine—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000696	0.00334	CbGpPWpGaD
Phenelzine—MAOA—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000695	0.00334	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00069	0.00331	CbGpPWpGaD
Phenelzine—MAOA—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000688	0.0033	CbGpPWpGaD
Phenelzine—CYP2E1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000642	0.00308	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000641	0.00308	CbGpPWpGaD
Phenelzine—CYP3A5—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00064	0.00307	CbGpPWpGaD
Phenelzine—MAOA—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000636	0.00305	CbGpPWpGaD
Phenelzine—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000613	0.00294	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000603	0.00289	CbGpPWpGaD
Phenelzine—MAOA—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000591	0.00284	CbGpPWpGaD
Phenelzine—MAOA—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000591	0.00284	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000572	0.00274	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000572	0.00274	CbGpPWpGaD
Phenelzine—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000555	0.00266	CbGpPWpGaD
Phenelzine—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000547	0.00263	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—DAO—amyotrophic lateral sclerosis	0.000545	0.00262	CbGpPWpGaD
Phenelzine—MAOA—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000527	0.00253	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000523	0.00251	CbGpPWpGaD
Phenelzine—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000495	0.00238	CbGpPWpGaD
Phenelzine—MAOA—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000487	0.00234	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000486	0.00233	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000474	0.00228	CbGpPWpGaD
Phenelzine—MAOA—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000468	0.00225	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000457	0.00219	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000436	0.00209	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000427	0.00205	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000413	0.00198	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—DAO—amyotrophic lateral sclerosis	0.000413	0.00198	CbGpPWpGaD
Phenelzine—CYP3A7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000396	0.0019	CbGpPWpGaD
Phenelzine—CYP3A7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000391	0.00188	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000391	0.00188	CbGpPWpGaD
Phenelzine—GPT—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000387	0.00186	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—GSR—amyotrophic lateral sclerosis	0.000381	0.00183	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000381	0.00183	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000363	0.00174	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—APOE—amyotrophic lateral sclerosis	0.000359	0.00172	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000359	0.00172	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000359	0.00172	CbGpPWpGaD
Phenelzine—GPT—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000355	0.00171	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000349	0.00167	CbGpPWpGaD
Phenelzine—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000345	0.00166	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000341	0.00164	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000328	0.00157	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000324	0.00156	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000313	0.0015	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000313	0.0015	CbGpPWpGaD
Phenelzine—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000308	0.00148	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000305	0.00146	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000305	0.00146	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000304	0.00146	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000304	0.00146	CbGpPWpGaD
Phenelzine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000298	0.00143	CbGpPWpGaD
Phenelzine—GPT—Metabolism—APOE—amyotrophic lateral sclerosis	0.000292	0.0014	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—GSR—amyotrophic lateral sclerosis	0.000289	0.00139	CbGpPWpGaD
Phenelzine—CYP2E1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000287	0.00138	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000287	0.00138	CbGpPWpGaD
Phenelzine—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000287	0.00138	CbGpPWpGaD
Phenelzine—CYP2E1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000283	0.00136	CbGpPWpGaD
Phenelzine—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000283	0.00136	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000278	0.00133	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—DAO—amyotrophic lateral sclerosis	0.000259	0.00124	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000258	0.00124	CbGpPWpGaD
Phenelzine—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000248	0.00119	CbGpPWpGaD
Phenelzine—GPT2—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000246	0.00118	CbGpPWpGaD
Phenelzine—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000245	0.00118	CbGpPWpGaD
Phenelzine—MAOA—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000243	0.00117	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000243	0.00117	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000237	0.00114	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000234	0.00112	CbGpPWpGaD
Phenelzine—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000222	0.00106	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00022	0.00106	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00022	0.00106	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	0.00022	0.00105	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00022	0.00105	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00022	0.00105	CbGpPWpGaD
Phenelzine—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000218	0.00105	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000209	0.001	CbGpPWpGaD
Phenelzine—MAOA—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000207	0.000992	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000201	0.000966	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000201	0.000964	CbGpPWpGaD
Phenelzine—GPT—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.0002	0.000962	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000196	0.000944	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00019	0.000913	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00019	0.000913	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000187	0.000898	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000187	0.000896	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—GSR—amyotrophic lateral sclerosis	0.000181	0.000871	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000177	0.000851	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000176	0.000845	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000176	0.000843	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000174	0.000835	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00017	0.000815	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00017	0.000815	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000168	0.000808	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000166	0.000799	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000162	0.000776	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	0.000159	0.000764	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	0.000159	0.000762	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000158	0.00076	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000155	0.000745	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000155	0.000743	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	0.000154	0.000738	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000152	0.00073	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000149	0.000715	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000144	0.000693	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	0.000137	0.00066	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000136	0.000652	CbGpPWpGaD
Phenelzine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000133	0.00064	CbGpPWpGaD
Phenelzine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000131	0.000631	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000128	0.000612	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—APOE—amyotrophic lateral sclerosis	0.000127	0.000611	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000126	0.000606	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	0.000123	0.000589	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000121	0.000579	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00012	0.000578	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000117	0.000563	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	0.000111	0.000534	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	0.000111	0.000533	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000104	0.0005	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000102	0.00049	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000102	0.00049	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—APOE—amyotrophic lateral sclerosis	9.64e-05	0.000463	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	9.62e-05	0.000462	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	9.34e-05	0.000448	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	9.3e-05	0.000447	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	9.14e-05	0.000439	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	9.12e-05	0.000438	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	8.76e-05	0.000421	CbGpPWpGaD
Phenelzine—CYP3A43—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.72e-05	0.000419	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.68e-05	0.000417	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	8.58e-05	0.000412	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	8.16e-05	0.000392	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—GSTP1—amyotrophic lateral sclerosis	8e-05	0.000384	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	7.9e-05	0.000379	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	7.82e-05	0.000375	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	7.38e-05	0.000354	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.35e-05	0.000353	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	7.21e-05	0.000346	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	7.05e-05	0.000338	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.78e-05	0.000326	CbGpPWpGaD
Phenelzine—MAOB—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.61e-05	0.000317	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	6.43e-05	0.000309	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.23e-05	0.000299	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—APOE—amyotrophic lateral sclerosis	6.05e-05	0.000291	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	5.59e-05	0.000269	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	5.16e-05	0.000248	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	5.13e-05	0.000246	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.94e-05	0.000237	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.91e-05	0.000236	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.9e-05	0.000235	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.51e-05	0.000217	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.5e-05	0.000216	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	4.41e-05	0.000212	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.24e-05	0.000204	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	4.24e-05	0.000204	CbGpPWpGaD
Phenelzine—MAOA—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.15e-05	0.000199	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.9e-05	0.000187	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.79e-05	0.000182	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	3.71e-05	0.000178	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	3.7e-05	0.000178	CbGpPWpGaD
Phenelzine—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.51e-05	0.000169	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.48e-05	0.000167	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	3.21e-05	0.000154	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	2.86e-05	0.000138	CbGpPWpGaD
Phenelzine—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.54e-05	0.000122	CbGpPWpGaD
Phenelzine—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.54e-05	0.000122	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.28e-05	0.000109	CbGpPWpGaD
Phenelzine—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.2e-05	0.000106	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.09e-05	0.000101	CbGpPWpGaD
Phenelzine—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.96e-05	9.42e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.72e-05	8.27e-05	CbGpPWpGaD
Phenelzine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.18e-05	5.67e-05	CbGpPWpGaD
